TP53 and melanoma: Using the publicly available pan-cancer TCGA dataset, we also observed a correlation between POLQ mRNA overexpression and TP53 mutation status in breast, lung, bladder, colorectal, gastric, glioblastoma, pancreatic, prostate, melanoma and uterine cancers (Figure 5B) (46–48).